Elisabet Ståhle

Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial

L. Wallentin, E. Swahn, S. Husted, 2000, The Lancet.

Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung

D. Djureinovic, M. Kamali-Moghaddam, P. Micke, 2019, BMC Cancer.

Quality of life following lung cancer surgery

G. Myrdal, M. Lambe, E. Ståhle, 2003, Thorax.